Latest Articles and Analysis

Nobel laureate's HCV vaccine development targeting 2029 offers hope alongside access equity challenges.

WHO 2030 HCV elimination goal at risk; only 5 of 110 countries on track as COVID-19 disrupts progress.

COVID-19 disrupts STI surveillance as staff redeployment, testing shortages, and clinic closures create gaps.

Restrictive Medicaid policies limit HCV treatment access through fibrosis restrictions and sobriety requirements.

Explores technology innovations in HIV care including mobile apps and drone pharmacy delivery.

UNAIDS report highlights HIV-HCV coinfection rates among people who inject drugs globally and in the US.

Supreme Court allows states to ration hepatitis C care in prisons, setting dangerous precedent for incarcerated people.

Housing instability increases HIV/HCV acquisition by 55-65%; housing investments outpace health interventions.

COVID-19 vaccination priority for people with HIV and chronic liver disease amid immunological risks.

COVID-19 vaccine development spurs reflection on 35-year HIV vaccine search and mRNA technology advances.

NASTAD's hepatitis C navigation toolkit uses peer navigators and wraparound services for people who use drugs.

Family courts and child welfare systems miss opportunities to address health needs and social determinants.

Multi-state Hepatitis A and B outbreaks linked to homelessness highlight housing as public health priority.

HHS releases integrated Viral Hepatitis National Strategic Plan calling for a syndemic approach with HIV and STI.

CANN outlines advocacy priorities for the Biden era, from 340B reform and drug pricing to HIV criminalization and health equity.